Andreas Calatzis: Revisiting a Widely Cited Study on Preoperative Screening for Primary Hemostasis Disorders
Andreas Calatzis, Managing Director of Eonis GmbH and Dynabyte GmbH, shared a post on LinkedIn:
“Happy weekend!
I’m pleased to share our new Perspective article in Frontiers in Medicine, coauthored with Michael Spannagl and Georg Wittmann.
We revisited a widely cited study on preoperative screening for primary hemostasis disorders, a study referenced in guidelines, in many reviews, and even prominently in the instructions for use of a popular platelet function analyzer.
Some weekend reading, if you would like to take a closer look:
- The original 2004 study
- Our Perspective
- A concise introduction to incorporation bias
I’m curious to hear your perspective on our ‘Perspective'”
Title 1: A Practical Concept for Preoperative Identification of Patients with Impaired Primary Hemostasis
Authors: Juergen Koscielny, Sabine Ziemer, Hartmut Radtke, Michael Schmutzler, Axel Pruss, Pranav Sinha, Abdulgabar Salama, Holger Kiesewetter, Reinhard Latza
Read the Full Article on Clinical and Applied Thrombosis/Hemostasis
Title 2: Circular validation in diagnostic research: re-examination of a widely cited study on primary hemostasis screening
Authors: Andreas Calatzis, Michael Spannagl, Georg Wittmann
Read the Full Article on Frontiers in Medicine
Title 3: Incorporation bias in studies of diagnostic tests: how to avoid being biased about bias
Authors: Andrew Worster, Christopher R Carpenter
Read the Full Article on Canadian Journal of Emergency Medicine
Find more posts featuring Andreas Calatzis on Hemostasis Today.
-
Oct 31, 2026, 19:40How Antiseizure Medication Selection May Influence DOAC Safety in Epilepsy – JAMA Neurology
-
Oct 31, 2026, 19:35Alejandro González Veliz: Balancing Ischemic Protection and Bleeding Risk in Antiplatelet Management
-
Oct 31, 2026, 19:29Sascha David: Therapeutic Plasma Exchange Associated with Lower 90 Day Mortality in Streptococcal Septic Shock
-
Oct 31, 2026, 19:25Jessica Garcia: Real-World Evidence on Efanesoctocog Alfa Prophylaxis in Pediatric Hemophilia A
-
Oct 31, 2026, 19:21Cedric Hermans: What If Higher Plasma FIX Levels Do Not Necessarily Mean better Haemostatic Protection?
-
Oct 31, 2026, 19:16Valance Washington: Celebrating Sravya Nimmala’s Outstanding Abstract Award
-
Oct 31, 2026, 16:41Ward Faisal: Ferric Carboxymaltose as an Alternative to Traditional Iron Preparations for Anemia
-
Oct 31, 2026, 16:35Bhavna Daryani: Using Technology to Make Anemia Screening More Accessible and Non-Invasive
-
Oct 31, 2026, 16:33Greg Jackson: Key Insights from the 22nd Annual McMaster Hematology and Thromboembolism Update